OncoHost, a technology company transforming the approach to precision medicine for improved patient outcomes, today announced a collaboration with Gustave Roussy, the first European cancer center, to ...

A new assay rapidly detected pancreatic ductal adenocarcinoma and differentiated it from noncancer pancreatic diseases by ...

Improving early detection is one of several holy grails in pancreatic cancer research. Many believe biomarkers — biological ...

SNS Insider Report Highlights 10.04% CAGR Growth Fueled by Technological Breakthroughs and Rising Global Cancer Burden.Pune, Feb. 26, 2025 (GLOBE NEWSWIRE) -- Tumor Profiling Market Size & Growth ...

The Providence Cancer Center at Alaska Medical Center in Anchorage, part of Renton, Wash.-based Providence, will become the first hospital in Alaska to offer the targeted prostate cancer therapy, ...

AI holds immense promise but also demands a careful, measured approach to yield the greatest benefit—especially for cancer ...

Colorectal cancer (CRC) is the second most commonly diagnosed cancer in China and a leading cause of cancer-related mortality ...

Melatonin supplement significantly boosts DNA repair markers, suggesting potential cancer prevention benefits - Anadolu ...

Keytruda has been approved since 2016 as a second-line option after chemotherapy for patients with more advanced HNSCC that ...

We think it can be appropriate to present phase 2 trial participation as offering a small prospect of benefit,” researchers wrote. About 16% of patients enrolled in phase 2 cancer trials receive a ...

A new proteomic aging clock may predict biological age, mortality risk, and the likelihood of age-related diseases, though ...

SEOUL, South Korea and WELLINGTON, New Zealand, /PRNewswire/ -- Lunit (KRX:328130.KQ), a leading provider of AI-powered ...